文献速递垂体与肾上腺疾病

接受治疗的肢端肥大症中GH与IGF-1结果不一致:GH切点及均值评估的影响

Discordant GH and IGF-1 Results in Treated Acromegaly: Impact of GH Cutoffs and Mean Values Assessment.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

结果显示不一致率随GH切点变化(1 µg/L为52.2%,2.5 µg/L为35.6%,P=0.025),采用3次GH均值可减轻切点影响,但GHf和GHm对IGF-1正常化的预测能力均较差。

要点

  • GH切点显著影响GH/IGF-1不一致率,1 µg/L时达52.2%,2.5 µg/L时为35.6%。
  • 采用3次GH均值可减轻切点对不一致率的影响(P=0.265)。
  • GHf和GHm对IGF-1正常化的预测能力均较差(AUC分别为0.611和0.645)。

核心结论

  • GH/IGF-1不一致率强烈依赖于GH切点,使用GH均值可减轻切点影响,但GH水平对IGF-1正常化预测能力差。

主要发现

  • 末次评估时GHf为1.99 ± 2.79 µg/L,年龄调整IGF-1f为0.86 ± 0.44 ×正常上限。
  • GHf切点1 µg/L时不一致率为52.2%,2.5 µg/L时为35.6%(P=0.025)。
  • GHf <1.0 µg/L时「高GH」不一致更常见,GHf <2.5 µg/L时「高IGF-1」更常见(P <0.0001)。
  • 使用GHm后不一致率:GHm <1.0 µg/L为43.3%,GHm <2.5 µg/L为38.9%(P=0.265)。
  • GHf和GHm预测IGF-1f正常化的AUC分别为0.611和0.645。

关键数值与推荐

  • GHf切点1 µg/L和2.5 µg/L对应的不一致率分别为52.2%和35.6%。
  • GHm <1.0 µg/L和<2.5 µg/L对应的不一致率分别为43.3%和38.9%。
  • GHf和GHm预测IGF-1f正常化的AUC分别为0.611和0.645。

临床怎么用

  • 临床解读GH/IGF-1不一致时需考虑GH切点选择,采用连续GH均值可能减少切点依赖。
  • 不应仅凭单次GH水平预测IGF-1正常化,需结合IGF-1综合评估疾病控制。

局限性

  • 未报告GHm的具体采样间隔细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Discordant growth hormone (GH) and insulin-like growth factor-1 (IGF-1) values are frequent in acromegaly. OBJECTIVE: To evaluate the impact of different GH cutoffs on discordance rate. To investigate whether the mean of consecutive GH measurements impacts discordance rate when matched to the last available IGF-1 value. DESIGN: Retrospective study. SETTING: Referral center for pituitary diseases. PATIENTS: Ninety acromegaly patients with at least 3 consecutive evaluations for GH and IGF-1 using the same assay in the same laboratory (median follow-up 13 years). INTERVENTIONS: Multimodal treatment of acromegaly. MAIN OUTCOME MEASURES: Single fasting GH (GHf) and IGF-1 (IGF-1f). Mean of 3 GH measurements (GHm), collected during consecutive routine patients' evaluations. RESULTS: At last evaluation GHf values were 1.99 ± 2.79 µg/L and age-adjusted IGF-1f was 0.86 ± 0.44 × upper limit of normality (mean ± SD). The discordance rate using GHf was 52.2% (cutoff 1 µg/L) and 35.6% (cutoff 2.5 µg/L) (P = 0.025). "High GH" discordance was more common for GHf <1.0 µg/L, while "high IGF-1" was predominant for GHf <2.5 µg/L (P < 0.0001). Using GHm mitigated the impact of GH cutoffs on discordance (GHm <1.0 µg/L: 43.3%; GHm <2.5 µg/L: 38.9%; P = 0.265). At receiver-operator characteristic curve (ROC) analysis, both GHf and GHm were poor predictors of IGF-1f normalization (area under the curve [AUC] = 0.611 and AUC = 0.645, respectively). The prevalence of disease-related comorbidities did not significantly differ between controlled, discordant, and active disease patients. DISCUSSION: GH/IGF-1 discordance strongly depends on GH cutoffs. The use of GHm lessen the impact of GH cutoffs. Measurement of fasting GH levels (both GHf and GHm) is a poor predictor of IGF-1f normalization in our cohort.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Campana C, Cocchiara F, Corica G, et al. Discordant GH and IGF-1 Results in Treated Acromegaly: Impact of GH Cutoffs and Mean Values Assessment. J Clin Endocrinol Metab. 2021. PMID: 33236108. doi:10.1210/clinem/dgaa859

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。